CoChat

Endocrinology: Melatonin potentiates testosterone-induced suppression of luteinizing hormone secretion in normal men

Anderson, R.A., Lincoln, G.A., Wu, F.C.W. · 1993 · Human Reproduction

The DOI matches its Crossref record.

Abstract

A total of 12 healthy adult men were recruited to investigate the effect of exogenous melatonin on the sensitivity of the hypothalamo-pituitary axis to sex steroid negative feedback. The experiment consisted of a double-blind, randomized cross-over trial during which all subjects received 100 mg oral melatonin or placebo at 1600 h for 14 days. Midway through each of the two treatments (day 8), 100 mg testosterone propionate i.m. (TP) was given at 0900 h. Blood samples for the measurement of luteinizing hormone (LH), follicle stimulating hormone (FSH), prolactin, testosterone and melatonin were taken at 0900 h on days 1, 3, 5, and daily from days 8–14. An additional blood sample was taken 8 h after the administration of testosterone. The interval between the melatonin and placebo treatment periods was 2 months. The oral administration of melatonin caused a pharmacological increase in the blood plasma concentration of melatonin which was maximum at 2 h and still above normal at 24 h. The daily treatment thus resulted in persistently high circulating levels of melatonin for 14 days. This treatment had no significant effect on the secretion of LH, FSH, prolactin or testosterone based on the first week of each study (melatonin compared with placebo). The injection of TP caused a rapid 3 to 4-fold increase in the plasma concentrations of testosterone which was at a maximum at 8 h and had returned to baseline within 4 days, with a similar pattern in both the melatonin and placebo periods. This dose of TP caused a decrease in the plasma concentrations of LH and FSH lasting 4 days; there was no change in the concentration of prolactin. The steroid-induced, time-dependent reduction in the plasma concentration of LH was significantly greater in the subjects receiving melatonin compared with placebo (analysis of variance P < 0.01); LH concentrations were suppressed to a greater extent and for one day longer during the administration of melatonin. This effect did not reach statistical significance for the changes in the plasma concentration of FSH. These results show that the sensitivity of the hypothalamo-pituitary axis to testosterone feedback is increased by pharmacological treatment with melatonin, and suggest novel strategies for the development of hormonal contraception in men.

Overview

Integrity signals

Registry

Crossref · 10.1093/oxfordjournals.humrep.a137940

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cited by

See all 23

Metadata

Authors
Anderson, R. A., Lincoln, G. A., & Wu, F. C. W.
Affiliations
MRC Centre for Reproductive Health (GB)
Venue
Human Reproduction
Published
1993-11
Volume
8
Issue
11
Pages
1819-1822
ISSN
  • 0268-1161 (ISSN-L)
  • 1460-2350
OpenAlex
W2219095418
Cited by
23
References
0
Citations by year
2026: 1 · 2025: 1 · 2023: 1 · 2021: 2 · 2019: 1 · 2014: 1 · 2013: 1 · 2012: 2
FWCI
1.66
Type
journal article
Language
en
Open access
closed
Locations
  • Human Reproduction (publishedVersion)
  • PubMed (publishedVersion)
  • Research Explorer (The University of Manchester) (publishedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
Keywords
melatonin, testosterone, luteinizing hormone, hypothalamic-pituitary-gonadal axis, negative feedback, testosterone propionate, follicle-stimulating hormone, prolactin, male contraception
MeSH terms
Absorption, Adult, Double-Blind Method, Drug Synergism, Follicle Stimulating Hormone, Humans, Kinetics, Luteinizing Hormone, Male, Melatonin, Middle Aged, Prolactin, Testosterone

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Endocrinology: Melatonin potentiates testosterone-induced suppression of luteinizing hormone secretion in normal men. https://app.cochat.ai/papers/10.1093/oxfordjournals.humrep.a137940
The paper
Anderson, R. A., Lincoln, G. A., & Wu, F. C. W. (1993). Endocrinology: Melatonin potentiates testosterone-induced suppression of luteinizing hormone secretion in normal men. Human Reproduction. https://doi.org/10.1093/oxfordjournals.humrep.a137940

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.